Advanced Synthesis Technologies for Custom Peptides
As your trusted CDMO partner, Amber LifeSciences supports a broad range of peptide services through three core synthesis approaches — solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and hybrid technology. Our process development team selects the right route based on peptide length, complexity, and production scale, delivering high-purity custom peptides from milligram research quantities to multi-kilogram cGMP supply.
6,000L+
Reactor Capacity
25+
Peptide DMFs
500+
Peptides Delivered
15+
Peptide Modalities
Why Choose Amber Peptides as Your Peptide CDMO?
Amber LifeSciences is a fully integrated peptide CDMO, delivering custom peptide synthesis and cGMP peptide manufacturing that meet global regulatory standards from the first batch. Our process development, purification, analytical R&D, and regulatory teams work as one across the peptide lifecycle — combining SPPS, LPPS, and hybrid synthesis with large-scale purification capacity to move your molecule from research quantities to commercial supply without a single technology transfer.
SPPS, LPPS and Hybrid Synthesis
Three peptide synthesis platforms under one roof, with the route selected on peptide length, sequence complexity, and target scale — not on what a single technology can accommodate.
Milligram to Multi-Kilogram Scale-Up
Continuous supply from research-grade quantities through clinical batches to commercial cGMP volumes, with no vendor changes or tech transfers between phases.
Complex Peptide Modalities
Cyclic and disulfide-bridged peptides, PEGylated and lipidated variants, azido peptides for click chemistry, peptide conjugates, and custom building blocks synthesised in-house.
Large-Scale Peptide Purification
Preparative HPLC with DAC columns, lyophilisation, and salt-formation purification delivering consistent high-purity peptide API at multi-kilogram scale — capacity, not just capability.
Analytical Development and Validation
Method development and validation, peptide mapping, impurity profiling, and reference standards by UPLC, HPLC, and HRMS, aligned to ICH guidelines.
Regulatory-Ready cGMP Manufacturing
Dedicated peptide suites operating to USFDA, EMA, and PMDA standards, backed by peptide DMFs, CTD dossiers, and IND/NDA CMC support from our Drug Regulatory Affairs team.
Your Peptide, Our Expertise – Start the Conversation with Amber
Fill the form for custom peptide synthesis support from research to commercial scale. Let’s talk!
Accelerate Peptide Drug Development with Amber Peptides
Choose Amber LifeSciences for efficient, reliable custom peptide synthesis, purification, and cGMP peptide manufacturing.
24/7 Fast Support
Experience round-the-clock support from our dedicated peptide development and manufacturing teams.
FREE Web-Consultation
Get a free consultation and expert guidance from our peptide synthesis and regulatory specialists.
What peptide synthesis technologies does Amber offer?
Amber provides solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and hybrid synthesis using segment condensation and ligation. The route is selected on peptide length, sequence complexity, and target scale, so short fragments, long-chain sequences, and structurally difficult peptides are all handled in-house without outsourcing any step.
What scale of custom peptide synthesis can Amber support?
We manufacture from milligram research quantities through clinical batches to multi-kilogram commercial supply. Because development, purification, and cGMP manufacturing sit within the same organisation, your programme scales without vendor changes or technology transfers between phases.
Can Amber manufacture complex and high-potency peptides?
Yes. Our capabilities cover cyclic and disulfide-bridged peptides, PEGylated and lipidated variants, azido peptides for click chemistry, and peptide conjugates. Dedicated OEB 4 and OEB 5 containment supports cytotoxic peptides, peptide-drug conjugates, and other high-potency peptide APIs without cross-contamination risk.
How does Amber ensure peptide purity and regulatory compliance?
Preparative HPLC with DAC columns, lyophilisation, and salt-formation purification deliver consistent high-purity peptide API, verified by UPLC, HPLC, and HRMS with full impurity profiling and peptide mapping. Manufacturing operates to USFDA, EMA, and PMDA cGMP standards, supported by peptide DMFs, CTD dossiers, and IND/NDA CMC documentation.
How does Amber accelerate peptide development timelines?
In-house synthesis of protected amino acids and peptide building blocks removes the raw-material and geographic concentration risks that stall most peptide programmes. Combined with parallel process development and analytical work — and zero tech transfer between phases — this compresses the path from first synthesis to validated commercial supply.
About Us
Discover the story and mission driving AmberLifeSciences forward.
